Antoine B. Douaihy

Antoine Douaihy practices at Western Psychiatric Institute and Clinic - Unit in Pittsburgh, Pennsylvania.

Antoine Douaihy's NPI, 1184697609, was assigned on February 8, 2006. Antoine Douaihy holds Pennsylvania license MD062067L.

Antoine Douaihy's primary practice is Western Psychiatric Institute and Clinic - Unit, at 3811 Ohara St, Pittsburgh, PA 15213.

Antoine Douaihy's primary practice is Western Psychiatric Institute and Clinic - Unit in Pittsburgh, Pennsylvania. Antoine Douaihy is also affiliated with UPMC Presbyterian. The medical group on file is University of Pittsburgh Physicians, Department of Radiology. Dmand AI also links Antoine Douaihy to 1 more group practice or clinic and 1 hospital outpatient department, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Antoine Douaihy practices, 4 sites in all. Vendor and product names are available with a free account.

Psychiatry is Antoine Douaihy's primary specialty in the NPI Registry, under taxonomy code 2084P0800X. Antoine Douaihy is licensed in Pennsylvania.

CMS data shows 57 Medicare services from Antoine Douaihy across 2 procedure codes in 2023, for 17 Medicare patients. Medicare paid $3,396 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 17 Medicare patients who saw Antoine Douaihy in 2024. 71% of them have schizophrenia and other psychoses, and 65% have alcohol and drug use disorders. Their average risk score is 1.29, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Antoine Douaihy's median patient age at 49, with 35% women.

In 2024, Antoine Douaihy wrote 80 Medicare Part D claims for 16 patients. 98% of them were for generic drugs. CMS names the drug for 13 of them, across 1 drug with 11 or more claims each, at $1,741 in total drug cost. In 2022, CMS named 24 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for Antoine Douaihy for performance year 2024, reported as part of a group.

Dmand AI links 70 papers to Antoine Douaihy, published from 2011 to 2025. 2016 was the busiest year, with 8. The most frequent topics are Substance-Related Disorders, Opioid-Related Disorders and Smoking Cessation. Antoine Douaihy has published most often in J Addict Med. Antoine Douaihy's most frequent co-authors are Ihsan M. Salloum, MD, Esa M. Davis and Raul N. Mandler, MD.

Dmand AI links Antoine Douaihy to 2 clinical trials. 1 is still active or recruiting. Conditions studied include Adolescent Behavior, Opioid-Related Disorders and Narcotic-Related Disorders.

CMS Open Payments shows 21 general payments to Antoine Douaihy from 1 drug or device company from 2017 to 2020. Consulting fees make up the largest share, 49% of the total. Alkermes, Inc. paid the most, $13,629.